Rethinking Buffer Management Through Integrated Downstream Processing cover art

Rethinking Buffer Management Through Integrated Downstream Processing

Rethinking Buffer Management Through Integrated Downstream Processing

Listen for free

View show details

This Season's Biggest Deal | $0.99/mo for 3 months + $20 Audible bonus

Auto-renews at $8.99/mo. after 3 months - terms apply.
Summary
Buffer preparation is one of those parts of downstream processing that has traditionally been treated as a given. Buffers must be prepared, stored, and available when the purification process needs them, and facilities have long been designed around that requirement. But as biomanufacturing has scaled up, the amount of space, equipment and labor devoted to buffer preparation has grown with it. That was the starting point for a recent podcast discussion with Sébastien Lefebvre, Vice President R&D at VERDOT, and Nainesh Shah, Senior Application Engineer at Asahi Kasei Bioprocess. The two companies collaborated on a study looking at what happens when inline buffer formulation is connected directly with chromatography, using Asahi Kasei Bioprocess’ MOTIV® Inline Buffer Formulation System together with VERDOT’s FlexiPro™ Chrom platform. The work is described in more detail in the white paper, Transform Downstream Processing with an Integrated Solution: Optimize Time, Space and Cost Using MOTIV® Inline Buffer Formulation with FlexiPro™ Chrom. For Lefebvre, the collaboration grew out of something he had seen firsthand while visiting a customer planning a new downstream processing facility. The chromatography equipment itself occupied only a relatively small portion of the installation. Buffer preparation required much more space and, just as importantly, much more manpower. That observation led to a broader question about whether buffer preparation and chromatography really needed to operate as separate activities. “The starting question was very simple,” Lefebvre said. “How can we do better by working together?” Buffer Demand Has Changed Shah pointed out that the role of buffer preparation has changed as biomanufacturing has grown. Earlier processes often relied on a relatively limited number of established buffers and smaller production batches. Today, he said, a single manufacturing batch can require 50,000 to 60,000 liters of buffer. Keeping up with that demand using a conventional approach can mean expanding tank farms, adding equipment and devoting more people to preparing, cleaning, testing and managing buffers. Inline formulation changes that equation. Instead of preparing every finished buffer in advance, facilities prepare concentrated stock solutions that can be blended into the required formulation when the process needs them. Shah described the shift as moving toward treating buffer generation more like a manufacturing utility. “It’s a game changer, and looking at it as a utility more makes sense,” he said. Lefebvre made an important distinction during the conversation. Inline formulation does not eliminate buffer preparation. Concentrated stock solutions still need to be made and stored. What changes is the complexity of that preparation. Rather than asking operators to prepare a series of finished buffers with the correct combinations of salts, buffering components and other ingredients, facilities can prepare simpler concentrates and let the system handle the final formulation. “The real benefit is not the elimination of the preparation but simplification,” Lefebvre said. “You move the complexity from manual preparation to an automated system.” That matters because buffer preparation has traditionally depended heavily on experienced operators. Even with well-trained staff, mistakes can happen, and they may not be caught until the buffer reaches quality control. By that point, correcting the problem can mean lost time, additional work and, in some cases, delays to the downstream process. Lefebvre sees advances in analytics and process control as a way to move more of that work into an automated and controlled environment. Letting Chromatography Drive Buffer Production The most interesting part of the collaboration comes from linking buffer formulation directly with chromatography. In the setup evaluated by VERDOT and Asahi Kasei Bioprocess, FlexiPro Chrom communicates the actual buffer demand to the MOTIV system in real time. Instead of preparing buffer based solely on a forecast of what the chromatography step is expected to use, the formulation system can respond to what the process is actually consuming. Shah sees that kind of interoperability as part of a broader change in bioprocessing. Manufacturers increasingly want to choose the equipment that works best for each part of the process, even when those systems come from different suppliers. The important thing is to make sure they can communicate. “They will buy the best and then make sure that they talk to each other,” Shah said. In this case, the systems communicate through OPC UA, allowing information to move between equipment from different suppliers in real time. Shah noted that the same principle can extend beyond this particular application. As more systems become connected, information from multiple skids can be brought into a central control environment rather than ...
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.